市場調查報告書

全球藥物釋放型球囊市場:成長,趨勢,預測(2020∼2025)

Drug Eluting Balloon Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925336
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
全球藥物釋放型球囊市場:成長,趨勢,預測(2020∼2025) Drug Eluting Balloon Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球藥物釋放型球囊市場在2020年∼2025年的預測期間內,預計將以18%的年複合成長率發展。在全世界增加的冠狀動脈疾病及週邊動脈疾病的發生率,預計推動市場成長。再加上政府和民間機關的研究開發增加,及心臟病相關意識的持續性配合措施,加速市場成長。

本報告提供全球全球藥物釋放型球囊市場調查,市場概要,各產品、技術、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素及市場機會分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 末梢及冠狀動脈疾病的盛行率的增加
    • 老年人口的增加
  • 市場阻礙因素
    • 產品開發與商品化的高成本
    • 有害作用與產品的回收
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場區隔

  • 各產品
    • 冠狀動脈塗藥氣球
    • 末梢藥物釋放型球囊
    • 其他
  • 各技術
    • FreePac
    • TransPac
    • EnduraCoat
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Medtronic Plc
    • Boston Scientific Corporation
    • Becton, Dickson and Company
    • Terumo Corporation
    • Koninklijke Philips NV
    • Cook Group Incorporated
    • Biotronik
    • B. Braun Melsungen AG
    • SurModics, Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 67876

The drug eluting balloon market is projected to grow with an approximate CAGR of 18%, during the forecast period. The increasing incidence of coronary and peripheral artery diseases around the world is expected to boost market growth. In addition, an increase in research and development supported by government and private institutions and continuous initiatives on awareness regarding heart diseases are fuelling the market growth.

According to the World Health Organization (WHO), every year 31% of world deaths (17.9 million) are caused by cardiovascular diseases. Increasing geriatric population, which is prone to cardiovascular diseases and growing healthcare spending is projected to bolster the market growth. However, the high cost of development and commercialization of drug eluting balloons coupled with stringent regulatory procedures are hampering the market growth.

Key Market Trends

Coronary Drug Eluting Balloons are Expected to Grow at Healthy Rate

  • Drug eluting balloons play an important role in the treatment of coronary artery diseases. Growing prevalence of coronary artery diseases coupled with increasing geriatric population is expected to boost the segment growth.
  • According to the British Heart Foundation, in 2016 Coronary Artery Diseases are leading cause of death worldwide.
  • Peripheral drug eluting balloons segment is projected to have significant share owing to the increased usage of drug eluting balloons in treatment of peripheral artery diseases and growing R&D in expanding the indications, new product launches in the peripheral artery segment.
  • Furthermore, the anticipated product launches coupled with the development of innovative coating and balloon technologies expected to boost the market growth over the forecast period.

North America is Expected to Have Significant Market Share

The factors such as the increasing prevalence of coronary artery diseases in the region. Furthermore, increasing obesity, which develops further cardiovascular diseases coupled with a sedentary lifestyle in the region expected to boost regional growth. According to Center for Disease Control and Prevention (CDC), in 2017, coronary heart disease killed about 365,914 people in the United States and about 20% of CAD deaths happen in people less than 65 years old. Owing to the presence of a large pool of people with heart diseases, growing healthcare spending especially in emerging countries of Asia expected to boost the market growth in the Asia-Pacific Region. Moreover, new product launches companies expanding into emerging Asian Countries projected to bolster the regional growth over the forecast period.

Competitive Landscape

Drug eluting balloon market is moderately consolidated and competitive. Companies are focusing on innovating the balloon technologies, expanding product indications and regions to expand their market share. For instance, in Feb 2019, MedAlliance S.A has received breakthrough device designation for its sirolimus drug-eluting balloon SELUTION. The key market players operating in the drug eluting balloon market include Medtronic Plc, Boston Scientific Corporation, Becton, Dickson and Company, Terumo Corporation, and Koninklijke Philips N.V. among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Peripheral and Coronary Artery Diseases
    • 4.2.2 Rising Geriatric Population, leading to Cardiovascular Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Development and Commercialization of Drug Eluting Balloons
    • 4.3.2 Adverse Effects and Product Recalls
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Coronary Drug Eluting Balloon
    • 5.1.2 Peripheral Drug Eluting Balloon
    • 5.1.3 Others (Renal/Urology)
  • 5.2 By Technology
    • 5.2.1 FreePac
    • 5.2.2 TransPac
    • 5.2.3 EnduraCoat
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Becton, Dickson and Company
    • 6.1.4 Terumo Corporation
    • 6.1.5 Koninklijke Philips N.V.
    • 6.1.6 Cook Group Incorporated
    • 6.1.7 Biotronik
    • 6.1.8 B. Braun Melsungen AG
    • 6.1.9 SurModics, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS